Literature DB >> 7933144

Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration.

M L Bosch1, A C Andeweg, R Schipper, M Kenter.   

Abstract

Variable regions with sequence length variation in the human immunodeficiency virus type 1 envelope exhibit an unusual pattern of codon usage with AAT, ACT, and AGT together composing > 70% of all codons used. We postulate that this distribution is caused by insertion of AAT triplets followed by point mutations and selection. Accumulation of the encoded amino acids (asparagine, serine, and threonine) leads to the creation of new N-linked glycosylation sites, which helps the virus to escape from the immune pressure exerted by virus-neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933144      PMCID: PMC237203     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Deoxyribo ucleic acid-directed synthesis of ribonucleic acid by an enzyme from Escherichia coli.

Authors:  M CHAMBERLIN; P BERG
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

Review 2.  Dynamic mutations: a new class of mutations causing human disease.

Authors:  R I Richards; G R Sutherland
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

3.  Codon usage tabulated from the GenBank genetic sequence data.

Authors:  K Wada; S Aota; R Tsuchiya; F Ishibashi; T Gojobori; T Ikemura
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

4.  Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1.

Authors:  D Davis; D M Stephens; C Willers; P J Lachmann
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

5.  Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.

Authors:  P Westervelt; D B Trowbridge; L G Epstein; B M Blumberg; Y Li; B H Hahn; G M Shaw; R W Price; L Ratner
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques.

Authors:  J Overbaugh; L M Rudensey
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

7.  Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.

Authors:  M S Fung; C R Sun; W L Gordon; R S Liou; T W Chang; W N Sun; E S Daar; D D Ho
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Authors:  J C Boyer; K Bebenek; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens.

Authors:  S Alexander; J H Elder
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

10.  Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.

Authors:  S Modrow; B H Hahn; G M Shaw; R C Gallo; F Wong-Staal; H Wolf
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

View more
  10 in total

1.  Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction.

Authors:  Yutaka Takebe; Alice Telesnitsky
Journal:  Virology       Date:  2006-06-14       Impact factor: 3.616

2.  Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.

Authors:  D G Fox; P Balfe; C P Palmer; J C May; C Arnold; J A McKeating
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein.

Authors:  K H Siebelink; W Huisman; J A Karlas; G F Rimmelzwaan; M L Bosch; A D Osterhaus
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.

Authors:  M Poss; A G Rodrigo; J J Gosink; G H Learn; D de Vange Panteleeff; H L Martin; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 5.  The HIV-1 env protein: a coat of many colors.

Authors:  Kathryn Twigg Arrildt; Sarah Beth Joseph; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

6.  Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.

Authors:  D L Lichtenstein; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.

Authors:  Kathryn M Kitrinos; Noah G Hoffman; Julie A E Nelson; Ronald Swanstrom
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough.

Authors:  Wenfeng An; Alice Telesnitsky
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.

Authors:  Brian J Rybarczyk; David Montefiori; Philip R Johnson; Ande West; Robert E Johnston; Ronald Swanstrom
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 10.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.